Related Experiment Videos
Exploitation of prostate gene expression to develop targeted therapies
1YCR Cancer Research Unit, Department of Biology, University of York, PO Box 373, York YO1 5YW, U.K. njm9@york.ac.uk
Acta Bio-Medica : Atenei Parmensis
|September 27, 2003
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Inhibition of c-FLIP alongside TRAIL treatment suppresses prostate cancer stem cell activity.
British journal of cancer·2026
ST6GAL1-mediated aberrant sialylation promotes prostate cancer progression.
The Journal of pathology·2023
An unusual cause of obstructing laryngeal edema: Forestier's disease. Case report and literature review.
Acta bio-medica : Atenei Parmensis·2026
IgA Vasculitis following AstraZeneca/Oxford COVID-19, case report.
Acta bio-medica : Atenei Parmensis·2023
Acute paraplegia in a patient with eosinophilic granulomatosis and polyangiitis with 20 years of evolution: case report.
Acta bio-medica : Atenei Parmensis·2023
The impact of pediatric congenital heart disease on primary teeth structure: a histological study.
Acta bio-medica : Atenei Parmensis·2023
Predictors of neuropathic dysesthetic pain occurrence and chronification in multiple sclerosis (2-year prospective study).
Acta bio-medica : Atenei Parmensis·2023
Rethinking Disease Progression in Transthyretin Amyloid Cardiomyopathy: Toward Mechanism-Specific Monitoring and Therapeutic Response Assessment.
Journal of the American College of Cardiology·2026
2026 Update on Clinical Trials in β-Thalassemia.
American journal of hematology·2026
Knowledgeable Language Models as Black-Box Optimizers for Personalized Medicine.
... International Conference on Learning Representations·2026
Durable LVAD therapy in end-stage methamphetamine-associated heart failure: a case report of the bridge to opportunity and transplant candidacy.
European heart journal. Case reports·2026
Construction and validation of a predictive model for HBsAg loss in chronic hepatitis B patients treated with Peg-IFNα-2b.
Frontiers in cellular and infection microbiology·2026